Drug Profile
Opal-HIV-Gag Clade C vaccine - Opal Therapeutics
Alternative Names: HIV immunotherapy - Opal Therapeutics/Massachusetts General Hospital; HIV vaccine - Opal Theraputics; Opal-HIV-Gag Clade C; Opal-HIV-Gag(c)Latest Information Update: 23 Mar 2018
Price :
$50
*
At a glance
- Originator Opal Therapeutics
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 23 Mar 2018 Discontinued - Phase-I for HIV infections in United Kingdom (Parenteral)
- 16 Jul 2016 No recent reports of development identified for phase-I development in HIV-infections in United Kingdom (Parenteral)
- 11 Jun 2010 Phase-I clinical trials in HIV infections in United Kingdom (Parenteral)